Vaxxas patch worked for all Covid strainsRead more
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.Learn more about who we are
A proprietary blood collection tube rapidly providing high quality serum for analysis from all bloods including anti-coagulatedView Project
Developing novel immuno-oncology small molecule inhibitorsView Project
Developing novel therapeutics for inflammatory diseasesView Project
Targeting long non-coding RNAs for next generation cancer therapiesView Project
Developing the next generation of CAR-T cell therapies to treat solid cancersView Project
Combining non-opioid analgesics and biopolymers to deliver weeks of localised pain managementView Project
Unlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infectionsView Project
Glyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.View Project
The Australian Institute of Tropical Health and Medicine (AITHM) is a multi-disciplinary health and tropical medicine research institute located in the tropics. Based at James Cook University in northern Queensland, AITHM has key nodes in Townsville, Cairns and the Torres Strait.View
The Walter and Eliza Hall Institute is the oldest medical research institute in Australia and will celebrate its centenary in 2015.
The institute is affiliated with The University of Melbourne and The Royal Melbourne Hospital and offers postgraduate training as the Department of Medical Biology of The University of Melbourne.
Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.Learn more
Australia’s first national biotech incubator announces round one funding to support life science breakthroughsRead more
Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory BoardRead more